2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Development and validation of diagnostic criteria for advanced Parkinson disease: the CDEPA questionnaire

M.-R. Luquin, J. Kulisevsky, P. Martinez-Martin, P. Mir, E. Tolosa, P. Garcia-Delgado (Pamplona, Spain)
Development of a Clinical Outcomes Assessment (COA) in Pantothenate-Kinase Associated Neurodegeneration (PKAN): Item Generation and Clinimetric Properties

R. Marshall, A. Collins, M. Escolar, H.A. Jinnah, T. Klopstock, M. Kruer, A. Videnovic, A. Robichaux-Viehoever, L. Swett, D. Revicki, R. Bender, W. Lenderking (Cambridge, MA, USA)
Development of a Clinician-reported Screening Tool to Identify Patients with Parkinson’s disease inadequately controlled on oral medications

A. Antonini, P. Schmidt, P. Odin, L. Kleinman, A. Skalicky, K. Sail, Y. Jalundhwala, J. Zamudio, K. Onuk, T. Marshall, H. Fernandez (Venice, Italy)
Development of a New Kinematic Model for Head and Neck Movement Assessment in Cervical Dystonia

A. Castagna, D. Anastasi, A. Crippa, L. Lanzotti, A. Montesano, A. Marzegan (Milano, Italy)
Development of a Paroxysmal Movement Disorder Diary for Patients with Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

R. Hall, S. Kilgariff, P. Collins, M. Brandabur, R. Arbuckle, A. Bowden (Macclesfield, United Kingdom)
Development of a prototype alpha-synuclein vaccine to induce T regulatory cells for the treatment of synucleonopathy

E. Rockenstein, G. Ostroff, F. Dikengil, F. Rus, M. Mante, J. Florio, A. Adame, I. Trinh, E. Masliah, R. Rissman (La Jolla, CA, USA)
Development of nano-formulation containing crocetin for the protective and beneficial effect against 6-hydroxydopamine induced Parkinson’s disease model via altered the genetic backgrounds

V. Kumar, A. Verma, P. Bhatt (Allahabad, India)
Development of utility to evaluate a symptomatic diary of motor fluctuations of Parkinson’s disease (PD) using a smartphone application.

H. Ohtsubo, H. Iwaki, H. Yabe, M. Nagai, M. Nomoto (Matsuyama Ehime, Japan)
Dextrometorphan/quinidine in Atypical Parkinsonisms and Huntington Disease

J. Etcheverry, M. Cesarini, G. Rojas, E. Gatto (Buenos Aires, Argentina)
Diabetes Mellitus and Parkinson’s Disease

G. Pagano, S. Polychronis, H. Wilson, F. Niccolini, M. Politis (London, United Kingdom)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z